Document is current
Any future updates will be listed below
-
Authors
Mangat, Pam K.
Kirkwood, M. Kelsey
Hinshaw, Dominique C.
Garrett-Mayer, Elizabeth
Schilsky, Richard L.
-
Funding
Funding for this research was provided by:
AstraZeneca
Bayer
Boehringer Ingelheim
Bristol Myers Squibb
Eli Lilly and Company
Genentech
Merck
Pfizer
Seagen
Taiho Oncology
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 26 May 2025
First Online: 3 July 2025
Competing interests
: R.L.S. declares leadership positions with Clarified Precision Medicine, Leap Therapeutics, stock and other ownership interests in Leap Therapeutics, honoraria with Toray Industries, consulting or advisory roles for Cellworks, Bryologyx, Illumina, Syapse, Zephyr AI, Flatiron Health, and Veracyte, and research funding from AstraZeneca, Bayer, Bristol Myers Squibb, Genentech/Roche, Lilly, Merck, Pfizer, Boehringer Ingelheim, Seagen, and Taiho Oncology. All other authors declare no competing interests.
